Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kleinert

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Nature|June 21, 1984
Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptideS A Atlas, H D Kleinert, M J Camargo, et al.
Journal of Medicinal Chemistry|June 1, 1989
Azido glycols: potent, low molecular weight renin inhibitors containing an unusual post scissile site residueS H Rosenberg, K W Woods, H D Kleinert, et al.
Circulation|September 1, 1983
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stressR B Devereux, T G Pickering, G A Harshfield, et al.
Journal of Medicinal Chemistry|December 1, 1988
Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stabilityJ J Plattner, P A Marcotte, H D Kleinert, et al.
American Journal of Hematology|December 12, 1997
Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophiliaJ J Goedert, D D Erdman, B A Konkle, et al.
Journal of Medicinal Chemistry|May 15, 1992
Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacementW R Baker, A K Fung, H D Kleinert, et al.
The American Journal of Cardiology|July 7, 1999
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusionP S Teirstein, J T Mann, P E Cundey, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Nature|June 21, 1984
Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptideS A Atlas, H D Kleinert, M J Camargo, et al.
Journal of Medicinal Chemistry|June 1, 1989
Azido glycols: potent, low molecular weight renin inhibitors containing an unusual post scissile site residueS H Rosenberg, K W Woods, H D Kleinert, et al.
Circulation|September 1, 1983
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stressR B Devereux, T G Pickering, G A Harshfield, et al.
Journal of Medicinal Chemistry|December 1, 1988
Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stabilityJ J Plattner, P A Marcotte, H D Kleinert, et al.
American Journal of Hematology|December 12, 1997
Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophiliaJ J Goedert, D D Erdman, B A Konkle, et al.
Journal of Medicinal Chemistry|May 15, 1992
Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacementW R Baker, A K Fung, H D Kleinert, et al.
The American Journal of Cardiology|July 7, 1999
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusionP S Teirstein, J T Mann, P E Cundey, et al.
Pageof 7